NuVasive Inc recalls X-CORE 2 Ti Core, Static. Part of the NuVasive X-Core Expandable VBR System used with spinal fixation.
- Recall date
- November 10, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0738-2023
- FDA classification
- Class II
- Brand / firm
- NuVasive Inc
- Sold / distributed
- Worldwide - U.S. Nationwide distribution including in the states of NC, CA, FL, KY, IL, TX, CO, OH, AK, GA, UT, MA, WA, HI, AL, NY, WI, AR, ID, VA, PA, SC, MD, PA, AZ, RI, IN, ME, NJ, MI, TN, MN, OR, OK, WY, and Puerto Rico. The countries of Australia, Belgium, Brazil, Colombia, Germany, Italy, Spa…
Why it was recalled
Potential that insert will be unable to disengage from the vertebral body replacement device/implant
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
X-CORE 2 Ti Core, Static. Part of the NuVasive X-Core Expandable VBR System used with spinal fixation.
Get recall alerts
Free email alert whenever NuVasive Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: NuVasive Inc